BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10843191)

  • 21. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
    Schmutzler C; Köhrle J
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters.
    Pohlenz J; Duprez L; Weiss RE; Vassart G; Refetoff S; Costagliola S
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2366-9. PubMed ID: 10902780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study.
    Caillou B; Troalen F; Baudin E; Talbot M; Filetti S; Schlumberger M; Bidart JM
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4102-6. PubMed ID: 9814499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells.
    Fierabracci P; Pinchera A; Tonacchera M; Agretti P; De Marco G; Albertini S; Conforti G; Seregni E; Agresti R; Grasso L; Giani C
    J Endocrinol Invest; 2004 Oct; 27(9):862-5. PubMed ID: 15648551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases.
    Yoshida A; Hisatome I; Taniguchi S; Shirayoshi Y; Yamamoto Y; Miake J; Ohkura T; Akama T; Igawa O; Shigemasa C; Kamijo K; Ikuyama S; Caturegli P; Suzuki K
    J Clin Endocrinol Metab; 2009 Feb; 94(2):442-8. PubMed ID: 19050049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa.
    Spitzweg C; Joba W; Eisenmenger W; Heufelder AE
    J Clin Endocrinol Metab; 1998 May; 83(5):1746-51. PubMed ID: 9589686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders.
    Figura N; Di Cairano G; Lorè F; Guarino E; Gragnoli A; Cataldo D; Giannace R; Vaira D; Bianciardi L; Kristodhullu S; Lenzi C; Torricelli V; Orlandini G; Gennari C
    J Physiol Pharmacol; 1999 Dec; 50(5):817-26. PubMed ID: 10695561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line.
    Smit JW; Shröder-van der Elst JP; Karperien M; Que I; van der Pluijm G; Goslings B; Romijn JA; van der Heide D
    Thyroid; 2000 Nov; 10(11):939-43. PubMed ID: 11128720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer.
    Castro MR; Bergert ER; Beito TG; Roche PC; Ziesmer SC; Jhiang SM; Goellner JR; Morris JC
    J Endocrinol; 1999 Dec; 163(3):495-504. PubMed ID: 10588823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Bucci I; Carpentieri M; Di Nenno B; Di Blasio A; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1080-7. PubMed ID: 22492869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis.
    Marinò M; Chiovato L; Friedlander JA; Latrofa F; Pinchera A; McCluskey RT
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2468-74. PubMed ID: 10404822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of autoantibodies against thyroid peroxidase in autoimmune thyroid disease: evidence against antibodies directly inhibiting peroxidase activity as regulatory factors in thyroid hormone metabolism.
    Saller B; Hörmann R; Mann K
    J Clin Endocrinol Metab; 1991 Jan; 72(1):188-95. PubMed ID: 1702446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immune response to the iodide transporter.
    Spitzweg C; Morris JC
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):389-98, viii. PubMed ID: 10874536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
    Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues.
    Jhiang SM; Cho JY; Ryu KY; DeYoung BR; Smanik PA; McGaughy VR; Fischer AH; Mazzaferri EL
    Endocrinology; 1998 Oct; 139(10):4416-9. PubMed ID: 9751526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.